Antibody Structure Explained: Heavy & Light Chains | Immunology

The five immunoglobulin classes differ in structure: IgM is pentameric with 10 carbohydrate molecules; IgG is monomeric with 4 carbohydrates; IgA is dimeric with 10 carbohydrates and has a hinge region; IgD is monomeric with 4 carbohydrates; IgE is monomeric with 12 carbohydrates. These structural differences determine their biological functions and locations in the body.

Immunoglobulins (antibodies) are Y-shaped globular proteins produced by plasma cells that consist of two heavy chains and two light chains, featuring Fab regions for antigen binding and Fc regions for effector functions; the five main classes include IgG (most abundant, crosses placenta, mediates secondary immune response), IgM (largest pentamer with 10 binding sites, initiates primary response), IgA (secretory antibody in mucosal surfaces), IgD (B-cell receptor function), and IgE (mediates allergic and inflammatory responses through mast cell activation).

The five main immunoglobulin classes (IgG, IgA, IgM, IgE, IgD) exhibit distinct structural and functional characteristics. IgG is the most abundant (80% of blood antibodies), exists as a monomer (150,000 MW), crosses placenta, and mediates complement-dependent destruction. IgA exists as monomers or dimers (160,000 MW) in secretions like saliva and tears, preventing pathogen entry. IgM is the largest (900,000 MW) with five Y-units, is first produced in immune response, and is most efficient against antigens. IgE is a monomer (190,000 MW) present in minute quantities, binds mast cells, and mediates allergic reactions through histamine release. IgD is a monomer (180,000 MW) expressed on B-cell surfaces as an antigen receptor without significant effector function. Each class serves specialized roles in immune defense.

Antibodies are classified into five major classes based on heavy chain constant regions: IgG, IgA, IgM, IgE, and IgD. IgM and IgE possess four constant domains (C1-C4), while IgG, IgA, and IgD have three constant domains (C1-C3). This structural diversity correlates with distinct functional properties. The classification reflects both structural organization and biological roles, demonstrating how antibody structure directly determines function in immune defense.

Immunoglobulins are Y-shaped proteins classified based on their heavy chains, comprising five types: IgG, IgA, IgM, IgD, and IgE. Each immunoglobulin consists of two heavy (H) chains and two light (L) chains, with each chain containing constant and variable regions. Structural cleavage by papain yields two Fab fragments (antigen-binding) and one Fc fragment, while pepsin cleavage produces different fragments. IgG is involved in the secondary immune response, opsonizes bacteria, fixes complement, neutralizes bacterial toxins and viruses, and uniquely crosses the placenta to provide passive immunity to the fetus. IgA prevents bacterial and viral attachment to mucous membranes and exists in two forms—serum IgA and secretory IgA—found in saliva, tears, colostrum, and milk. IgM mediates the primary immune response, fixes complement, and serves as an antigen receptor on the surface of B cells. IgD also functions as an antigen receptor on B cells but has no known effector function. IgE mediates immediate hypersensitivity reactions and plays a key role in defense against helminthic and worm infections. All five immunoglobulins share the same basic structural framework but differ in function due to variations in their constant regions.

Antibodies have multiple functions: opsonization (enhancing phagocytosis), complement activation, ADCC (antibody-dependent cell-mediated cytotoxicity), agglutination (clumping pathogens), and neutralization (blocking pathogen receptors). The Fc region binds Fc receptors on immune cells, triggering effector functions.

Humoral immunity is mediated by secreted antibodies providing defense against microbes and toxins. Antibodies have multiple effector functions including neutralization (blocking microbe penetration and toxin binding), opsonization (IgG coating microbes for phagocytosis), ADCC (NK cell-mediated cytotoxicity), complement activation, and inflammation. All functions are mediated by Fc regions while variable regions bind antigens. Major antibody isotypes include IgG (opsonization, complement activation, ADCC, neonatal immunity), IgM (most potent classical complement activator), IgA (mucosal immunity), and IgE (parasite defense and hypersensitivity).

The Fc region interacts with cell surface receptors called Fc receptors and also interacts with proteins of the complement system. These interactions allow antibodies to activate the immune system. The Fc region determines the antibody's class and its specific effector functions in immune defense.

Three major Fc-dependent mechanisms control infections after viruses enter cells. Complement activation involves antibodies binding to infected cells, with Fc regions activating C1q to trigger a cascade forming pores that destroy infected cells. Antibody-dependent phagocytosis (opsonization) uses Fc regions to bind Fc receptors on phagocytes, dramatically increasing engulfment efficiency. Antibody-dependent cell-mediated cytotoxicity (ADCC) involves NK cells binding antibody Fc regions to infected cells, releasing granzymes and perforins to kill them. These mechanisms work together to eliminate infected cells and control intracellular infections.

Antibodies have three main effector functions: (1) opsonization - coating pathogens to enhance phagocytosis, (2) antibody-dependent cell-mediated cytotoxicity (ADCC) - recruiting NK cells to kill target cells, and (3) complement activation - triggering the classical complement pathway. The classical complement pathway is activated by antibody-antigen complexes and leads to complement activation, which enhances pathogen destruction through opsonization, inflammation, and direct lysis via the membrane attack complex.

Monoclonal antibodies act through: blocking ligand-receptor binding (e.g., EGFR inhibitors), inducing immune-mediated cytotoxicity (ADCC, CDC), and serving as drug delivery vehicles. Diagnostic applications include Western blot, ELISA, flow cytometry for HIV detection (p24 antigen), myocardial necrosis, and colorectal cancer (CEA marker). Preventive applications include anti-platelet P2Y12 receptor antibodies for thrombosis prevention and anti-IL-2 receptor antibodies for transplant rejection prevention. Therapeutic applications include anti-RSV antibodies, anti-HER2 for breast cancer, anti-TNF-alpha for autoimmune diseases, and anti-EGFR for colorectal cancer.

Hybridoma technology produces monoclonal antibodies by fusing antibody-producing B cells with immortal myeloma cells. Selection in HAT medium exploits differential purine salvage pathway requirements: B cells can survive without de novo purine synthesis, while myeloma cells cannot. Only hybridoma cells inherit both capabilities. Applications include diagnostics (ELISA, Western blot), cancer detection, cell markers, research tools, and therapeutics (targeted drug delivery, cancer treatment, infectious disease therapy).

Western blotting is a laboratory technique used to identify specific proteins in a sample by separating proteins via SDS-PAGE, transferring them onto a nitrocellulose membrane using electroblotting, and detecting them through antibody-based colorimetric assays; the process involves assembling a blotting sandwich with gel, blotting paper, and membrane, running it at 20V for 2.5 hours, blocking non-specific binding sites, incubating with primary and secondary antibodies, and developing a color signal to visualize target proteins.

Monoclonal antibodies serve diverse medical purposes across diagnostics and therapeutics. Diagnostic applications include AIDS detection via ELISA, cancer identification through tumor markers, hormonal disorder assessment (thyroid hormones, HCG for pregnancy), and pregnancy testing. Therapeutic applications encompass fighting infections, cancer treatment, AIDS management, autoimmune disease modulation, and organ transplant rejection prevention. Additionally, monoclonal antibodies enable protein purification and serve as imaging agents when labeled with radioactive isotopes for visualizing internal tissues and pathological conditions.

Detection uses primary and secondary antibody systems. Primary antibodies specifically recognize target protein structures, requiring correct design to avoid cross-reactivity. Secondary antibodies bind primary antibodies and carry detectable tags (enzymes, fluorescent agents) for visualization through chemiluminescence, fluorescence, or colorimetric methods. In clinical diagnostics, Western blotting confirms HIV infection by detecting patient antibodies against viral proteins (p160, p120, p41). Interpretation criteria: positive requires p41 plus p120/p160; negative shows no bands; indeterminate shows unexpected bands (p24/p31) requiring retesting. Software like ImageJ analyzes band intensities to compare normal versus treated/diseased samples, revealing expression changes that indicate treatment efficacy or disease state.